Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Envoy Medical, Inc. (NASDAQ: COCH)
COCH Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-17%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
81.60%
COCH Stock Analysis
COCH
PE Ratio:
COCH
PEG Ratio:
Not Available
COCH
Forward EPS Growth (12 month):
0.00%
COCH
PS Ratio:
61.8
COCH
PSG Ratio:
Not Available
COCH
Forward Revenue Growth (12 month):
0.00%
COCH Articles
No data was found